Published in Am J Transplant on January 07, 2008
Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89
Early post-transplant survival: Interaction of MELD score and hospitalization status. J Hepatol (2015) 2.06
Variation in organ quality between liver transplant centers. Am J Transplant (2011) 1.99
Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center. Ann Surg (2011) 1.98
Kidneys from donors after cardiac death provide survival benefit. J Am Soc Nephrol (2010) 1.76
Moderate ascites identifies patients with low model for end-stage liver disease scores awaiting liver transplantation who have a high mortality risk. Liver Transpl (2011) 1.67
Portal vein thrombosis and liver transplant survival benefit. Liver Transpl (2010) 1.42
Development of organ-specific donor risk indices. Liver Transpl (2012) 1.26
Access to liver transplantation in the MELD era: role of ethnicity and insurance. Dig Dis Sci (2008) 1.21
Model for end-stage liver disease: end of the first decade. Clin Liver Dis (2011) 1.20
Comparative effectiveness of donation after cardiac death versus donation after brain death liver transplantation: Recognizing who can benefit. Liver Transpl (2012) 1.08
Impact of body mass index on posttransplant outcomes reexamined. Liver Transpl (2015) 1.08
Effect of pretransplant serum creatinine on the survival benefit of liver transplantation. Liver Transpl (2009) 1.06
Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05
A review of quality of life instruments used in liver transplantation. J Hepatol (2009) 1.03
Sex-based disparities in liver transplant rates in the United States. Am J Transplant (2011) 1.02
Experience Since MELD Implementation: How Does the New System Deliver? Int J Hepatol (2012) 0.92
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation. World J Gastroenterol (2013) 0.92
The SPLIT research agenda 2013. Pediatr Transplant (2013) 0.90
The evolution in the prioritization for liver transplantation. Ann Gastroenterol (2012) 0.87
Impact of donor and recipient race on survival after hepatitis C-related liver transplantation. Transplantation (2012) 0.87
Liver transplantation for alcohol-related cirrhosis: a single centre long-term clinical and histological follow-up. Dig Dis Sci (2010) 0.87
Dorsal muscle group area and surgical outcomes in liver transplantation. Clin Transplant (2014) 0.87
Cyclopamine attenuates acute warm ischemia reperfusion injury in cholestatic rat liver: hope for marginal livers. Mol Pharm (2011) 0.83
Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach. Hepatology (2016) 0.82
Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls. AIDS (2016) 0.82
Organ quality and quality of life after liver transplantation. Liver Transpl (2011) 0.82
Pretransplant prediction of posttransplant survival for liver recipients with benign end-stage liver diseases: a nonlinear model. PLoS One (2012) 0.82
Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine. Hepat Med (2013) 0.82
Transplant benefit for patients with hepatocellular carcinoma. World J Gastroenterol (2013) 0.81
Model for End-Stage Liver Disease, Model for Liver Transplantation Survival and Donor Risk Index as predictive models of survival after liver transplantation in 1,006 patients. Clinics (Sao Paulo) (2015) 0.81
Hepatitis C infection and hepatocellular carcinoma in liver transplantation: a 20-year experience. HPB (Oxford) (2013) 0.80
Pilot test of a patient decision aid about liver transplant organ quality. Liver Transpl (2014) 0.80
Outcomes following liver transplantation in intensive care unit patients. World J Hepatol (2013) 0.79
Rescue policy for discarded liver grafts: a single-centre experience of transplanting livers 'that nobody wants'. HPB (Oxford) (2010) 0.78
Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol (2017) 0.78
Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther (2012) 0.77
D-MELD risk capping improves post-transplant and overall mortality under markov microsimulation. World J Transplant (2014) 0.77
A proposal to grade the severity of early allograft dysfunction after liver transplantation. Einstein (Sao Paulo) (2013) 0.76
Recipient Hyperbilirubinemia May Reduce Ischemia-Reperfusion Injury but Fails to Improve Outcome in Clinical Liver Transplantation. Gastroenterol Res Pract (2016) 0.75
Waitlist Outcomes of Liver Transplant Candidates Who Were Reprioritized Under Share 35. Am J Transplant (2016) 0.75
Decision support for organ offers in liver transplantation. Liver Transpl (2015) 0.75
Recent advances in understanding and managing liver transplantation. F1000Res (2016) 0.75
Factors Associated with Mortality and Graft Failure in Liver Transplants: A Hierarchical Approach. PLoS One (2015) 0.75
Effects of Donor Age and Cold Ischemia on Liver Transplantation Outcomes According to the Severity of Recipient Status. Dig Dis Sci (2016) 0.75
Living donor liver transplantation for high model for end-stage liver disease score: What have we learned? World J Hepatol (2016) 0.75
Moving toward the utilization of all donated liver grafts. The "b-list" concept. Hippokratia (2012) 0.75
Transplantation: Sharing of donated livers is not equal. Nat Rev Gastroenterol Hepatol (2012) 0.75
Left Diaphragmatic Herniation following Orthotopic Liver Transplantation in an Adult. Case Rep Surg (2015) 0.75
SIMULTANEOUS LIVER KIDNEY TRANSPLANTATION IN LIVER TRANSPLANT CANDIDATES WITH RENAL DYSFUNCTION: IMPORTANCE OF CREATININE LEVELS, DIALYSIS, AND ORGAN QUALITY IN SURVIVAL. KI Rep (2016) 0.75
Liver-allocation policies for patients affected by HCC in Europe. Curr Transplant Rep (2016) 0.75
Developing a donation after cardiac death risk index for adult and pediatric liver transplantation. World J Transplant (2017) 0.75
Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03
Structural basis for the binding of proline-rich peptides to SH3 domains. Cell (1994) 6.34
Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature (1998) 6.32
The complex and intriguing lives of PIP2 with ion channels and transporters. Sci STKE (2001) 4.45
Patient, center and geographic characteristics of nationally placed livers. Am J Transplant (2012) 3.16
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89
Paternal population history of East Asia: sources, patterns, and microevolutionary processes. Am J Hum Genet (2001) 2.71
A risk prediction model for delayed graft function in the current era of deceased donor renal transplantation. Am J Transplant (2010) 2.69
Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant (2010) 2.04
Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant (2008) 2.04
Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant (2010) 2.02
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Regulatory intramolecular association in a tyrosine kinase of the Tec family. Nature (1997) 1.95
Borrelia burgdorferi strain-specific Osp C-mediated immunity in mice. Infect Immun (1997) 1.93
Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology (1997) 1.83
Protective and arthritis-resolving activity in sera of mice infected with Borrelia burgdorferi. Clin Infect Dis (1997) 1.74
Nomogram to predict the presence of EGFR activating mutation in lung adenocarcinoma. Eur Respir J (2011) 1.74
First-pass metabolism of cyclosporin by the gut. Lancet (1991) 1.71
Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant (2006) 1.68
Serum-mediated resolution of Lyme arthritis in mice. Lab Invest (1996) 1.68
CYP3A gene expression in human gut epithelium. Pharmacogenetics (1994) 1.66
Acquisition and transmission of the agent of human granulocytic ehrlichiosis by Ixodes scapularis ticks. J Clin Microbiol (1998) 1.64
Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62
Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology (1992) 1.62
Frailty predicts waitlist mortality in liver transplant candidates. Am J Transplant (2014) 1.62
The riskiest job in medicine: transplant surgeons and organ procurement travel. Am J Transplant (2009) 1.58
Randomized controlled trial of hand-assisted laparoscopic versus open surgical live donor nephrectomy. Transplantation (2001) 1.58
A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology (1995) 1.56
Preoperative risk factor assessment in liver transplantation. Surgery (1992) 1.55
Dynamic challenges inhibiting optimal adoption of kidney paired donation: findings of a consensus conference. Am J Transplant (2013) 1.55
Decreased risk of graft failure with maternal liver transplantation in patients with biliary atresia. Am J Transplant (2011) 1.54
Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients. Antimicrob Agents Chemother (2000) 1.50
Belatacept-based immunosuppression in de novo liver transplant recipients: 1-year experience from a phase II randomized study. Am J Transplant (2014) 1.50
Simultaneous liver-kidney transplantation summit: current state and future directions. Am J Transplant (2012) 1.50
Trends in organ donation and transplantation in the United States, 1999-2008. Am J Transplant (2010) 1.47
Utilization of kidneys with similar kidney donor risk index values from standard versus expanded criteria donors. Am J Transplant (2012) 1.46
Phosphatidylinositol 4,5-bisphosphate induces actin stress-fiber formation and inhibits membrane ruffling in CV1 cells. J Cell Biol (2001) 1.43
Delta 9-tetrahydrocannabivarin (delta 9-THCV) as a marker for the ingestion of cannabis versus Marinol. J Anal Toxicol (1999) 1.43
Negative words on surgical wards result in therapeutic failure of patient-controlled analgesia and further release of cortisol after abdominal surgeries. Minerva Anestesiol (2008) 1.41
The galE gene of Campylobacter jejuni is involved in lipopolysaccharide synthesis and virulence. Infect Immun (2000) 1.41
Effect of 24-h blood pressure levels and circadian blood pressure rhythm on left ventricular structure and function in isolated systolic hypertension. Int J Cardiol (1994) 1.39
A procedure to overcome interferences caused by the adulterant "Klear" in the GC-MS analysis of 11-nor-delta9-THC-9-COOH. J Anal Toxicol (1997) 1.39
Posttransplant diabetes mellitus in liver transplant recipients: risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation (2001) 1.38
Granulocytic ehrlichiosis in the laboratory mouse. J Infect Dis (1998) 1.37
Five unique compounds: xyloketals from mangrove fungus Xylaria sp. from the South China Sea coast. J Org Chem (2001) 1.37
Clinical Trial of the Pan-Caspase Inhibitor, IDN-6556, in Human Liver Preservation Injury. Am J Transplant (2007) 1.36
Versatile retrovirus vector systems for regulated gene expression in vitro and in vivo. Mol Med (1997) 1.35
Health-related quality of life in kidney donors from the last five decades: results from the RELIVE study. Am J Transplant (2013) 1.34
Complications of living donor hepatic lobectomy--a comprehensive report. Am J Transplant (2012) 1.32
Effects of intraarticular IL1-Ra for acute anterior cruciate ligament knee injury: a randomized controlled pilot trial (NCT00332254). Osteoarthritis Cartilage (2012) 1.30
Structure-function analysis of SH3 domains: SH3 binding specificity altered by single amino acid substitutions. Mol Cell Biol (1995) 1.26
Simultaneous liver-kidney transplantation: evaluation to decision making. Am J Transplant (2007) 1.22
Hand-assisted laparoscopic live donor nephrectomy. Urology (1998) 1.19
Inhibition of growth of malignant rat prostate tumor cells by restoration of fibroblast growth factor receptor 2. Cancer Res (1998) 1.19
Demographic, metabolic, and blood pressure characteristics of living kidney donors spanning five decades. Am J Transplant (2012) 1.19
Trends in organ donation and transplantation in the United States, 1998-2007. Am J Transplant (2009) 1.18
Impact of MELD-based allocation on end-stage renal disease after liver transplantation. Am J Transplant (2011) 1.17
Interaction of PIP(2) with the XIP region of the cardiac Na/Ca exchanger. Am J Physiol Cell Physiol (2000) 1.15
Association of bone scintigraphic abnormalities with knee malalignment and pain. Ann Rheum Dis (2008) 1.14
ASTS recommended practice guidelines for controlled donation after cardiac death organ procurement and transplantation. Am J Transplant (2009) 1.13
Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant (2008) 1.13
[Clinical treatment of hepatic and abdominal hydatid cyst by percutaneous puncture, drainage and curettage]. Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi (1994) 1.12
Trends in organ donation and transplantation in the United States, 1997-2006. Am J Transplant (2008) 1.10
Risk factors for urinary complications after renal transplantation. Am J Transplant (2007) 1.10
Race and ethnicity in access to and outcomes of liver transplantation: a critical literature review. Am J Transplant (2009) 1.08
Rapid eye movement sleep deprivation selectively impairs recall of fear extinction in hippocampus-independent tasks in rats. Neuroscience (2006) 1.08
MR arthrography of the glenohumeral joint: a tailored approach. AJR Am J Roentgenol (2001) 1.08
Delta9-tetrahydrocannabivarin as a marker for the ingestion of marijuana versus Marinol: results of a clinical study. J Anal Toxicol (2001) 1.07
Cyclosporin toxicity at therapeutic blood levels and cytochrome P-450 IIIA. Lancet (1990) 1.07
Coordination polymers: structural transformation from two to three dimensions through ligand conformation change. Inorg Chem (2000) 1.06
Excess risk of renal allograft loss associated with cigarette smoking. Transplantation (2001) 1.02
Sex-based disparities in liver transplant rates in the United States. Am J Transplant (2011) 1.02
Renal duplex Doppler ultrasonography: a noninvasive predictor of kidney dysfunction and hepatorenal failure in liver disease. Hepatology (1994) 1.02
Characterization of a 30-kDa Borrelia burgdorferi substrate-binding protein homologue. Res Microbiol (1997) 1.01
Transcatheter embolization of biopsy-related vascular injury in the transplant kidney: immediate and long-term outcome. J Vasc Interv Radiol (1999) 1.00
Photon migration in the presence of a single defect: a perturbation analysis. Appl Opt (1995) 1.00
Liver and intestine transplantation in the United States, 1996-2005. Am J Transplant (2007) 1.00
Use of high technology imaging for surveillance of early stage breast cancer. Breast Cancer Res Treat (2011) 1.00
Liver and intestine transplantation in the United States, 1995-2004. Am J Transplant (2006) 0.99
The economic implications of broader sharing of liver allografts. Am J Transplant (2011) 0.98
delta 9-THC metabolites in meconium: identification of 11-OH-delta 9-THC, 8 beta,11-diOH-delta 9-THC, and 11-nor-delta 9-THC-9-COOH as major metabolites of delta 9-THC. J Anal Toxicol (1998) 0.98
Acquisition dynamics of Borrelia burgdorferi and the agent of human granulocytic ehrlichiosis at the host-vector interface. Vector Borne Zoonotic Dis (2001) 0.97
Early renal allograft rejection episodes are less aggressive with cyclosporin-A immunosuppression. Transplant Proc (1983) 0.96
Prospective, case matched comparison of hand assisted laparoscopic and open surgical live donor nephrectomy. J Urol (2000) 0.96
Gender differences in liver donor quality are predictive of graft loss. Am J Transplant (2011) 0.96
Livin promotes Smac/DIABLO degradation by ubiquitin-proteasome pathway. Cell Death Differ (2006) 0.95
Innovations in the assessment of transplant center performance: implications for quality improvement. Am J Transplant (2009) 0.95
Transplant center quality assessment using a continuously updatable, risk-adjusted technique (CUSUM). Am J Transplant (2006) 0.94
Aortic revascularization of orthotopic liver allografts: indications and long-term follow-up. Surgery (1993) 0.94
STAT5 induces macrophage differentiation of M1 leukemia cells through activation of IL-6 production mediated by NF-kappaB p65. J Immunol (2001) 0.94